David Brindley

Dr. David Brindley is an experienced life science C-level executive and Board Member, specializing in cell/gene/viral therapies and digital health. Under Dr. Brindley’s leadership, multiple therapeutics and medical devices have achieved market approvals in the U.S, EMEA and ASEAN supporting transactions, including IPOs, trade sales and joint ventures. Dr. Brindley has published more than 100 peer reviewed publications in high impact journals, including Nature, Nature Biotechnology and Cell Stem Cell.